Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veru Inc. - Common Stock (NQ: VERU )

0.4915 -0.0023 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 765,432
Open 0.4804
Bid (Size) 0.4822 (5)
Ask (Size) 0.5000 (50)
Prev. Close 0.4938
Today's Range 0.4804 - 0.5064
52wk Range 0.4750 - 1.920
Shares Outstanding 146,383,920
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Traders are paying attention to the gapping stocks in Monday's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough
Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results are due in April 2025. 
Via Benzinga

Performance

YTD
-24.59%
-24.59%
1 Month
-14.24%
-14.24%
3 Month
-33.09%
-33.09%
6 Month
-43.37%
-43.37%
1 Year
-22.11%
-22.11%

More News

Read More
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December
Via Benzinga
Topics Economy
Exposures Interest Rates
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
Critical Insights From Veru Analyst Ratings: What You Need To Know
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
Which stocks are experiencing notable movement on Monday?
Via Chartmill
S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
These stocks are moving in today's session
Via Chartmill
Dow Edges Higher; AT&T Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
Via FinancialNewsMedia
Exposures COVID-19
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
From FN Media Group LLC
Via GlobeNewswire
VERU Stock Earnings: Veru Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Comstock And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
VERU Stock Earnings: Veru Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN
Via AB Newswire
Exposures Product Safety
The 3 Best Penny Stocks to Buy in February 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.